Compare Marriott International Inc (MAR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marriott International Inc vs GeneDx Holdings Corp — how do they compare? Marriott International Inc trades at $349.88 (market cap $91.14B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: Marriott International Inc is far larger — about 37.4× GeneDx Holdings Corp's market cap, and Marriott International Inc pays a 0.84% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| MAR | WGS | |
|---|---|---|
Market Cap | $91.14B | $2.44B |
Sector | Consumer Cyclical | Technology |
52-Week High | $402.54 | $167.51 |
52-Week Low | $259.04 | $34.51 |
Enterprise Value | $108.45B | $2.48B |
Dividend Yield | 0.84% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Marriott International (MAR) trades at $348.44, down 1.55% on the day, with a bearish technical signal and mixed earnings performance. The company reported Q2 2026 EPS of $3.19, beating estimates, but revenue growth faces headwinds. Key risks include high debt levels and valuation concerns, while analyst consensus remains positive with a $387.31 price target.
Outlook: MAR's fee-based model and loyalty program drive growth, but elevated P/E of 36.18 and rising debt-to-asset ratio warrant caution. Upside hinges on sustained RevPAR gains and effective cost management amid global economic uncertainty.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marriott International Inc
Marriott International Inc. of Maryland is a worldwide operator and franchisor of hotels. The Company franchises lodging facilities and vacation timesharing resorts under various brand names. Marriott also provides services to home and condominium owner associations for projects associated with several of its brands.
Read more on MAR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
